Citius Pharmaceuticals Bolsa (NASDAQ: CTXR)

Citius Pharmaceuticals (NASDAQ:CTXR) Bolsa, Quote.MetaTitle.unusual-options

Citius Pharma

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals Inc

AN2 Therapeutics

Athira Pharma

Aytu BioPharma

Cingulate

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical

Cumberland Pharmaceuticals Inc. - Common Stock

Cumberland

Citius Pharmaceuticals

Curanex Pharmaceuticals Inc - Common Stock

Curanex Pharmaceuticals

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics

Dare Bioscience

Evoke Pharma

Hoth Therapeutics

IGC Pharma

Iterum Therapeutics

Lexaria Bioscience

Lipocine

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

NewcelX

Processa Pharmaceuticals, Inc. - Common Stock

Processa Pharmaceuticals

Pulmatrix

PolyPid

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares

Quantum BioPharma

SCYNEXIS

SenesTech

TherapeuticsMD

Verrica Pharmaceuticals Inc. - Common Stock

Verrica Pharmaceuticals

Citius Pharmaceuticals (CTXR) Previsión

Noticias

Beneficios

Opciones

Calificaciones de analistas

Operaciones de insiders

Interés en corto

Informe de acciones

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Comments

Citius Pharmaceuticals Opciones Inusuales

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL